ADIPOQ and type 2 diabetes mellitus: Recent studies conducted in animals or in humans have demonstrated a direct and causal effect of iron stores in circulating levels of adiponectin, independently of other peripheral markers of inflammation [20], [21], thus explaining the attenuated association between ferritin and incident type 2 diabetes mellitus observed after adjustment for circulating adiponectin levels [5].